Agilent Technologies Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
9.6%projected annual EPS growth
Analyst Coverage
19analysts covering
FY Revenue (est.)
$7.4Bnext fiscal year
FY EPS (est.)
$6.06next fiscal year
Monitoring Framework
Key Performance Indicators
Core Organic Revenue Growth Quarterly6.3%Target: 4% to 6% full-year core growth range
Non-GAAP Operating Margin Quarterly26.4%Target: Strategic pricing expansion of 100-200 bps
Quarterly Revenue Quarterly1.8BTarget: Full-year FY2026 guidance of $7.39 billion - $7.49 billion
Watch Items
- Biocare Acquisition IntegrationTrigger: Integration delays or costs exceeding the $950 million cash purchase price expectationsAction: Re-evaluate diagnostics segment growth trajectory and margin impact
- Academia and Government Lab SpendingTrigger: Continued weakness in U.S. federal funding affecting lab equipment budgetsAction: Adjust Life Sciences and Applied Markets segment forecasts
- Tariff and Supply Chain Margin PressuresTrigger: Gross margin contraction due to rising international tariffs or shipping costsAction: Assess pricing power adjustments via the Ignite operating system
Research as of 2 Sep 2026